Sensitive high-throughput plasma proteomics: Key technology for deep phenotyping

Identifying early markers of transitions between human health and disease is a key objective of systems medicine. The strategy involves collecting diverse longitudinal data for each individual, before and after symptoms manifest. This deep phenotyping is made possible by a range of technologies, including proteomics.However, until recently, a rate-limiting step was the collection of comprehensive plasma proteomics.

Join this webinar to learn how this bottleneck has been removed using high-throughput and high-sensitivity protein profiling with Olink® technology coupled with SPT Labtech’s liquid handling automation.

Key learning objectives

• Learn how longitudinal deep phenotyping, including plasma proteomics, is central to systems medicine, the study of complex disease, and biomarker discovery
• Find out the importance of establishing baseline measurements and reference ranges for normal human plasma, which can also signal outliers in undiagnosed disease
• Discover how potential prognostic markers of severe and "long" COVID-19 were identified in the plasma proteome
• Learn how adopting an Olink and SPT Labtech bundled infrastructure can deliver high throughput and uncompromised data quality for genomics, single cell, RNA seq and much more

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.